294 related articles for article (PubMed ID: 12495560)
1. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H; Naito T; Takeyama M
J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide and somatostatin releases correlated with the area under the lafutidine concentration-time curve in human plasma.
Ikawa K; Shimatani T; Azuma Y; Inoue M; Morikawa N
J Clin Pharm Ther; 2006 Aug; 31(4):351-6. PubMed ID: 16882104
[TBL] [Abstract][Full Text] [Related]
3. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma.
Katagiri F; Sato Y; Itoh H; Takeyama M
J Pharm Pharmacol; 2004 Apr; 56(4):557-61. PubMed ID: 15099451
[TBL] [Abstract][Full Text] [Related]
4. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
5. Ecabet sodium raises plasma levels of calcitonin generelated peptide and substance P in healthy humans.
Katagiri F; Inoue S; Sato Y; Itoh H; Takeyama M
J Pharm Pharmacol; 2005 Jun; 57(6):799-805. PubMed ID: 15969937
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
Reich A; Orda A; Wiśnicka B; Szepietowski JC
Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
[TBL] [Abstract][Full Text] [Related]
7. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopharmacological study of gastrointestinal drugs from the viewpoint of postmarketing development].
Itoh H
Yakugaku Zasshi; 2006 Sep; 126(9):767-78. PubMed ID: 16946590
[TBL] [Abstract][Full Text] [Related]
10. Lafutidine, a novel histamine H2-receptor antagonist, increases serum calcitonin gene-related peptide in rats after water immersion-restraint stress.
Sato H; Kawashima K; Yuki M; Kazumori H; Rumi MA; Ortega-Cava CF; Ishihara S; Kinoshita Y
J Lab Clin Med; 2003 Feb; 141(2):102-5. PubMed ID: 12577045
[TBL] [Abstract][Full Text] [Related]
11. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
[TBL] [Abstract][Full Text] [Related]
12. Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma.
Sato Y; Itoh H; Suzuki Y; Tatsuta R; Takeyama M
J Clin Pharm Ther; 2013 Feb; 38(1):19-23. PubMed ID: 23030252
[TBL] [Abstract][Full Text] [Related]
13. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions of H2-receptor antagonists.
Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
[TBL] [Abstract][Full Text] [Related]
16. Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
Segawa Y; Takei M; Omata T; Tsuzuike N; Yamaji Y; Kurimoto T; Ozeki M; Tagashira E
Arzneimittelforschung; 1991 Sep; 41(9):950-3. PubMed ID: 1796923
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
18. Alterations in colonic arterial and venous plasma neuropeptide concentrations in horses during low-flow ischemia and reperfusion of the large colon.
Moore RM; Charalambous AC; Masty J
Am J Vet Res; 1996 Aug; 57(8):1200-5. PubMed ID: 8836375
[TBL] [Abstract][Full Text] [Related]
19. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
20. Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma.
Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
Electrophoresis; 2001 Aug; 22(13):2717-22. PubMed ID: 11545397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
